OCUMENSION THERAPEUTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.81 HKD | +5.26% |
|
+14.65% | +1.95% |
| 15/04 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
| 15/04 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
Chart calendar Ocumension Therapeutics
05190fcb0cf1d47.rtGkuzkrmvjey1xRcoGjNJbwiEBQpRkBGfRrnR7Mft4.nryU3w1R-YC9siw0B_XOAPuV-hNn0nFvQbse6maaOI70u83yTh7Jz7i5EQ~a602ca60d5bb7b92c3e70b9bf955b0f7
Upcoming events on Ocumension Therapeutics
Past events on Ocumension Therapeutics
| 21/03/2024 | Q4 2023 Earnings Release |
| 24/08/2023 | Q2 2023 Earnings Release |
| 30/03/2023 | Q4 2022 Earnings Release |
| 26/08/2022 | Interim 2022 Earnings Release |
| 25/03/2022 | FY 2021 Earnings Release |
| 20/08/2021 09:49 pm | Interim 2021 Earnings Release |
| 29/06/2021 07:30 am | Annual General Meeting |
| 21/03/2021 | FY 2020 Earnings Release |
| 26/08/2020 | Interim 2020 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 13,1 23,3 -43.85% | 56,1 58,6 -4.21% | 159 163 -2.45% | 246 261 -5.53% |
|
EBITDA Million CNY | Released Forecast Spread | -447 -377 -18.67% | -384 -403 4.73% | -452 -265 -70.41% | -393 -213 -84.56% |
|
EBIT Million CNY | Released Forecast Spread | -452 -379 -19.29% | -386 -422 8.58% | -456 -357 -27.69% | -402 -366 -9.75% |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 0,00 0,00 - | -260 -438 40.64% | -402 -329 -22.21% | -379 -424 10.49% |
|
Net income Million CNY | Released Forecast Spread | 0,00 0,00 - | -260 -438 40.64% | -403 -388 -3.74% | -380 -424 10.5% |
|
EPS CNY | Released Forecast Spread | 0,00 0,00 - | -0,43 -0,65 33.72% | -0,64 -0,59 -8.56% | -0,59 -0,62 4.15% |
| Announcement Date | 19/03/21 | 25/03/22 | 30/03/23 | 21/03/24 |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 11,1 35,2 -68.34% | 20,8 33,4 -37.63% | 35,3 46,2 -23.49% | 54,5 36,0 51.69% | 104 101 3.09% | 104 122 -15.2% | 143 148 -3.32% | 170 | 260 | |
|
EBIT Million CNY | Released Forecast Spread | -180 -202 10.9% | -206 -270 23.58% | -219 -173 -26.11% | -237 -244 2.62% | -225 -233 3.35% | -177 -207 14.31% | -152 | -133 | ||
|
Net income Million CNY | Released Forecast Spread | -1 742 | |||||||||
|
EPS CNY | Released Forecast Spread | -27,0 | -0,31 -0,23 -34.78% | -0,33 -0,34 2.94% | -0,32 -0,32 0% | -0,27 -0,28 3.57% | |||||
| Announcement Date | 26/08/20 | 19/03/21 | 20/08/21 | 25/03/22 | 26/08/22 | 30/03/23 | 24/08/23 | 21/03/24 | - | - |
More events
Past sector events for Ocumension Therapeutics
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 1477 Stock
- Calendar Ocumension Therapeutics
